225 related articles for article (PubMed ID: 25488803)
1. A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes.
Hill R; Kalathur RK; Callejas S; Colaço L; Brandão R; Serelde B; Cebriá A; Blanco-Aparicio C; Pastor J; Futschik M; Dopazo A; Link W
Breast Cancer Res; 2014 Dec; 16(6):482. PubMed ID: 25488803
[TBL] [Abstract][Full Text] [Related]
2. FOXO target gene CTDSP2 regulates cell cycle progression through Ras and p21(Cip1/Waf1).
Kloet DE; Polderman PE; Eijkelenboom A; Smits LM; van Triest MH; van den Berg MC; Groot Koerkamp MJ; van Leenen D; Lijnzaad P; Holstege FC; Burgering BM
Biochem J; 2015 Jul; 469(2):289-98. PubMed ID: 25990325
[TBL] [Abstract][Full Text] [Related]
3. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
[TBL] [Abstract][Full Text] [Related]
4. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
[TBL] [Abstract][Full Text] [Related]
5. Extracellular ATP regulates FoxO family of transcription factors and cell cycle progression through PI3K/Akt in MCF-7 cells.
Scodelaro Bilbao P; Boland R
Biochim Biophys Acta; 2013 Oct; 1830(10):4456-69. PubMed ID: 23742826
[TBL] [Abstract][Full Text] [Related]
6. The expression of the tumour suppressor HBP1 is down-regulated by growth factors via the PI3K/PKB/FOXO pathway.
Coomans de Brachène A; Bollaert E; Eijkelenboom A; de Rocca Serra A; van der Vos KE; Burgering BM; Coffer PJ; Essaghir A; Demoulin JB
Biochem J; 2014 May; 460(1):25-34. PubMed ID: 24762137
[TBL] [Abstract][Full Text] [Related]
7. Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer.
Qazi AK; Hussain A; Khan S; Aga MA; Behl A; Ali S; Singh SK; Taneja SC; Shah BA; Saxena AK; Mondhe DM; Hamid A
Cancer Lett; 2015 Apr; 359(1):47-56. PubMed ID: 25554016
[TBL] [Abstract][Full Text] [Related]
8. FOXO transcription factors enforce cell cycle checkpoints and promote survival of hematopoietic cells after DNA damage.
Lei H; Quelle FW
Mol Cancer Res; 2009 Aug; 7(8):1294-303. PubMed ID: 19671690
[TBL] [Abstract][Full Text] [Related]
9. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
10. Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases.
Link W; Oyarzabal J; Serelde BG; Albarran MI; Rabal O; Cebriá A; Alfonso P; Fominaya J; Renner O; Peregrina S; Soilán D; Ceballos PA; Hernández AI; Lorenzo M; Pevarello P; Granda TG; Kurz G; Carnero A; Bischoff JR
J Biol Chem; 2009 Oct; 284(41):28392-28400. PubMed ID: 19690175
[TBL] [Abstract][Full Text] [Related]
11. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors.
Terragni J; Graham JR; Adams KW; Schaffer ME; Tullai JW; Cooper GM
BMC Cell Biol; 2008 Jan; 9():6. PubMed ID: 18226221
[TBL] [Abstract][Full Text] [Related]
13. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
14. Modulation of FoxO signaling in human hepatoma cells by exposure to copper or zinc ions.
Walter PL; Kampkötter A; Eckers A; Barthel A; Schmoll D; Sies H; Klotz LO
Arch Biochem Biophys; 2006 Oct; 454(2):107-13. PubMed ID: 16973122
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
16. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells.
Aggarwal S; John S; Sapra L; Sharma SC; Das SN
Cancer Chemother Pharmacol; 2019 Mar; 83(3):451-461. PubMed ID: 30519710
[TBL] [Abstract][Full Text] [Related]
18. CNK1 is a novel Akt interaction partner that promotes cell proliferation through the Akt-FoxO signalling axis.
Fritz RD; Varga Z; Radziwill G
Oncogene; 2010 Jun; 29(24):3575-82. PubMed ID: 20383191
[TBL] [Abstract][Full Text] [Related]
19. Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway.
Lin CH; Chang CY; Lee KR; Lin HJ; Chen TH; Wan L
BMC Cancer; 2015 Dec; 15():958. PubMed ID: 26675309
[TBL] [Abstract][Full Text] [Related]
20. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
